STERIS plc (STE)
Healthcare · Medical - Specialties · Data as of 2026-10-22
Bottom line
STE is trading at a discount to its history, near its historical support zone, and recent volume shows no clear direction. Historically, this combination has been a favourable starting point for further research. Past patterns are not a guarantee of future results.
Valuation — Trading at a discount to its history (Green)
STE trades at 27× earnings, below its own 5-year average of 49× and roughly in line with similar healthcare companies we track (28×, 53 peers). Historically this has been on the cheaper side for the stock. Its free-cash-flow yield is about 4.2%. Its current multiple sits around the 8th percentile of its own last five years — toward the low end of its own range. Its fundamentals scored 9 of 9 on a standard year-over-year quality checklist — most of the underlying trends improved last fiscal year.
Price zones — Near its historical support zone (Green)
At $232.22, the stock is close to the lower end of its recent range. Over the past year STE has traded between $195.14 and $269.44; its historical support zone sits near $225.64 and resistance near $269.44. It is above both its 50- and 200-day averages, which has historically signalled an uptrend.
52-week range $195.14–$269.44 · 50-day average $220.34 · 200-day average $225.64
Money flow — No clear direction (Yellow)
Buying and selling volume in STE have been fairly balanced recently, with no strong accumulation or distribution pattern. Volume on up days has been about 0.8× volume on down days over the last 30 sessions.
Dividends & company facts
STE paid $2.58 a share in dividends over the past year — 1.1% of today's price — and has raised it in each of the last five years. It also bought back shares: $203 million in fiscal 2026, about 0.92% of its market value.
- Dividend yield (12 months)
- 1.11%
- Paid over 12 months
- $2.58 a share
- Payout ratio
- 30.7%
- Buybacks
- 0.92% (fiscal 2026)
- Shares, past year
- -0.9%
- Revenue, 12 months
- $6.0B
- Profit, 12 months
- $805M
- Employees
- 17,937
- CEO
- Daniel A. Carestio
- Headquarters
- Mentor, OH
- Listed since
- 1992 · NYSE
About the company
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions.
Related stocks
一句话结论
STE 相对自身历史处于折价水平，接近其历史支撑区，近期成交量没有明确方向。从历史来看，这样的组合是一个值得进一步研究的有利起点。过去的形态并不能保证未来的结果。
估值 — 相对自身历史处于折价水平
STE 目前的市盈率为 27×，低于其自身 5 年平均的 49×，并且大致持平于我们追踪的同类Healthcare公司（28×，53 家）。从历史来看，这属于该股较便宜的一侧。其自由现金流收益率约为 4.2%。它当前的估值倍数大约位于自身过去五年分布的第 8 百分位——处于自身区间的偏低位置。在一套标准的逐年基本面核对清单上，它 9 项中通过了 9 项——上一财年多数底层趋势在改善。
价格区间 — 接近其历史支撑区
目前价格为 $232.22，接近其近期区间的下沿。过去一年 STE 的价格在 $195.14 到 $269.44 之间波动；其历史支撑区在 $225.64 附近，阻力区在 $269.44 附近。它同时位于 50 日和 200 日均线上方，这在历史上通常对应上升趋势。
资金流向 — 方向不明确
STE 近期的买卖成交量大致均衡，没有明显的吸筹或派发形态。过去 30 个交易日，上涨日的成交量约为下跌日的 0.8×。
股息与公司概况
STE 过去一年每股派息 2.58 美元，相当于当前股价的 1.1%，过去五年每年都有上调。它也回购了股票：2026 财年回购 2.0亿美元，约占市值的 0.92%。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.